Cargando…

Why Are We Not There Yet?

[Figure: see text]

Detalles Bibliográficos
Autor principal:	Wenger, Nanette K.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2021
Materias:	Viewpoint
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8302791/ https://www.ncbi.nlm.nih.gov/pubmed/34317608 http://dx.doi.org/10.1016/j.jaccas.2021.02.028

Ejemplares similares

Why Biological Psychiatry Hasn’t Delivered Yet – and Why Neurology Knows
por: Frisch, Stefan
Publicado: (2021)

Paediatric HIV: we are not done yet!
por: Penazzato, Martina
Publicado: (2020)

Genetic Testing in Evaluating Risk of Anthracycline Cardiomyopathy: Are We There Yet?
por: Wong-Siegel, Jeannette R., et al.
Publicado: (2023)

Are we there yet? 40 years of successes and challenges for children and adolescents living with HIV
por: Vreeman, Rachel C, et al.
Publicado: (2021)

Precision Medicine for Breath-Focused Mind-Body Therapies for Stress and Anxiety: Are We Ready Yet?
por: Lavretsky, Helen, et al.
Publicado: (2021)

The path to hepatitis C elimination: who are we leaving behind and why?
por: Rockstroh, Jurgen K., et al.
Publicado: (2023)

Why Reducing Low-Value Care Fails to Bend the Cost Curve, and Why We Should Do it Anyway
por: Kroon, Daniëlle, et al.
Publicado: (2023)

Prevention of cardiovascular disease: why do we neglect the most potent intervention?
por: Stamatakis, Emmanuel, et al.
Publicado: (2009)

Brexit and health security: why we need to protect our global networks
por: Solomon, Danielle
Publicado: (2019)

Why do we need international standards on responsible research publication for authors and editors?
por: Wager, Elizabeth, et al.
Publicado: (2013)

Why We Are Losing the War Against COVID-19 on the Data Front and How to Reverse the Situation
por: Prieto-Merino, David, et al.
Publicado: (2021)

Why machine learning (ML) has failed physical activity research and how we can improve
por: Fuller, Daniel, et al.
Publicado: (2022)

COVID-19: Why Declining Biodiversity Puts Us at Greater Risk for Emerging Infectious Diseases, and What We Can Do
por: Khetan, Aditya K.
Publicado: (2020)

Are we there yet? The transition from response to recovery for the COVID-19 pandemic
por: Fakhruddin, Bapon (SHM), et al.
Publicado: (2020)

The evolving schistosomiasis agenda 2007-2017—Why we are moving beyond morbidity control toward elimination of transmission
por: King, Charles H.
Publicado: (2017)

Structure versus function: Are new conformations of pannexin 1 yet to be resolved?
por: Mim, Carsten, et al.
Publicado: (2021)

The impact of COVID-19 pandemic on AIDS-related mycoses and fungal neglected tropical diseases: Why should we worry?
por: Nargesi, Sanaz, et al.
Publicado: (2021)

Why we should all be more careful in drawing conclusions about how COVID-19 is changing drug markets
por: Giommoni, Luca
Publicado: (2020)

Coxitis in axial spondyloarthritis: the unmeasured, yet functionally most important, radiographic progression
por: Rocha, Francisco Airton Castro, et al.
Publicado: (2021)

A call to action for universal health coverage: Why we need to address gender inequities in the neglected tropical diseases community
por: Ozano, Kim, et al.
Publicado: (2020)

Clinical Xenotransplantation of Organs: Why Aren't We There Yet?
por: Mohiuddin, Muhammad M
Publicado: (2007)

The management of multi-morbidity in elderly patients: Ready yet for precision medicine in intensive care?
por: Beil, Michael, et al.
Publicado: (2021)

Blood eosinophil level to predict chronic obstructive pulmonary disease clinical outcomes: not ready yet
por: Cai, Cheng-Sen, et al.
Publicado: (2019)

Why don’t we have an effective tuberculosis vaccine yet?
por: Davenne, Tamara, et al.
Publicado: (2016)

Complementary yet distinct roles for oestrogen receptor-α and oestrogen receptor-β in mouse mammary epithelial proliferation
por: Clarke, Robert B
Publicado: (2004)

Viewpoint | European COVID-19 exit strategy for people with severe mental disorders: Too little, but not yet too late
por: De Picker, Livia J., et al.
Publicado: (2021)

Tranexamic acid in pediatric trauma: why not?
por: Beno, Suzanne, et al.
Publicado: (2014)

Teaching professionalism – Why, What and How
por: Cruess, S.R., et al.
Publicado: (2012)

Women leaders: transforming the culture in cardiology
por: Eshtehardi, Parham, et al.
Publicado: (2022)

Why have we embraced minimally invasive surgery and ignored enhanced recovery after surgery?
por: Nanavati, Aditya J, et al.
Publicado: (2016)

Why Measure Patient Experience in Physical Therapy?
por: Eversole, Jacob, et al.
Publicado: (2021)

Why Arboviruses Can Be Neglected Tropical Diseases
por: LaBeaud, A. Desiree
Publicado: (2008)

Redefining ‘stress resistance genes’, and why it matters
por: Maron, Lyza G., et al.
Publicado: (2016)

Section 377: Why sodomy statutes matter
por: Beyrer, Chris
Publicado: (2019)

Implementation of Self-Management Interventions in Cancer Survivors: Why Are We Not There Yet?
por: Rimmer, Ben, et al.
Publicado: (2021)

Why Female Athletes Injure Their ACL’s More Frequently? What can we do to mitigate their risk?
por: Silvers-Granelli, Holly
Publicado: (2021)

Living on the edge with too many mouths to feed: Why dopamine neurons die
por: Bolam, J Paul, et al.
Publicado: (2012)

Why Is Plasmodium vivax a Neglected Tropical Disease?
por: Carlton, Jane M., et al.
Publicado: (2011)

Why is noma a neglected-neglected tropical disease?
por: Srour, M. Leila, et al.
Publicado: (2020)

Beyond Notes: Why It Is Time to Abandon an Outdated Documentation Paradigm
por: Steinkamp, Jackson, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_ddugdqj9trbgpkbcbv57ecvbgr